NEW YORK (GenomeWeb News) – OvaGene Oncology today announced the opening of its new clinical and research laboratory in Irvine, Calif., where the company is headquartered.
The facility will serve as the central headquarter for operations, research, and molecular clinical lab testing, OvaGene said in a statement. Technologies used for genomic testing on cancer cells at the facility include qPCR, comparative genomic hybridization, and gene expression arrays.
OvaGene is in the process of pursuing clinical laboratory licensure and accreditation. If it is successful, the company will offer molecular diagnostics to the gynecological community, it said. In addition, the company will develop diagnostics based on in-licensed technologies and internal research. The research will include collaborations with pharma firms in the oncology space in order to develop companion diagnostics.
OvaGene develops and commercializes personalized DNA-based diagnostics for gynecologic cancer.